<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="854">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04784468</url>
  </required_header>
  <id_info>
    <org_study_id>UNIVIE_Covid_Oxstress</org_study_id>
    <nct_id>NCT04784468</nct_id>
  </id_info>
  <brief_title>DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients</brief_title>
  <acronym>ABCD</acronym>
  <official_title>DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients Compared to Healthy Controls: A Case-control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SMZ-Ost Donauspital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the&#xD;
      coronavirus disease 2019 (COVID-19) pandemic challenging health systems worldwide.&#xD;
&#xD;
      While there is a clear correlation between oxidative stress markers and the severity of many&#xD;
      viral diseases such as hepatitis C, for SARS-CoV clinical data is limited.&#xD;
&#xD;
      The investigators aim at 1.) investigating DNA damage, oxidative stress, inflammation, and&#xD;
      aging markers in COVID-19 patients and compare them with age and gender matched healthy&#xD;
      controls and patients with influenza; and 2.) investigating all aforementioned parameters&#xD;
      during &quot;cytokine storm&quot; via repeated blood sampling.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 19, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>DNA damage</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare DNA damage (% of DNA in the tail; measured by the comet assay) between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The investigators will consider further DNA damage parameter</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare other DNA damage endpoints measured with the comet assay (i.e. tail length, tail moment and damage index) between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The investigators will consider oxidative stress marker</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare oxidative stress biomarker malondialdehyde, FRAP, GSH, GSSG (all µmol/L) and the ration GSH/GSSG between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The investigators will consider inflammatory marker</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare inflammatory marker Interleukin 1 (IL-1), IL-6, IL-8, IL-10, TNF-alpha (all rfU) and CRP (mg/dl) between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The investigators will consider the phenotypic age marker</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare the phenotypic age marker between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The investigators will consider RDA and DNA gene expression</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare RNA and DNA gene expression between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The investigators will consider clinical biochemistry marker</measure>
    <time_frame>Baseline</time_frame>
    <description>Compare clinical biochemistry (Total cholesterol (mg/dl), LDL-cholesterol (mg/dl), triglycerides (mg/dl), blood glucose (mg/dl), uric acid (mg/dl)) between hospitalized COVID-19 patients to influenza patients and healthy controls.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Covid-19</arm_group_label>
    <description>Covid-19 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Influenza</arm_group_label>
    <description>Influenza patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cotrol</arm_group_label>
    <description>Control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>Case-control design, one single investigation</description>
    <arm_group_label>Cotrol</arm_group_label>
    <arm_group_label>Covid-19</arm_group_label>
    <arm_group_label>Influenza</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Covid 19 patients:&#xD;
&#xD;
        Cases after hospital admission.&#xD;
&#xD;
        Influenza:&#xD;
&#xD;
        Cases after confirmed influenza diagnosis&#xD;
&#xD;
        Healthy controls:&#xD;
&#xD;
        Healthy subjects from the general population&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Covid 19 group:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  gender: female/male&#xD;
&#xD;
          -  age: ≥40 years&#xD;
&#xD;
          -  patients admitted at the emergency department&#xD;
&#xD;
          -  COVID-19 suspected patients&#xD;
&#xD;
          -  able to give written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  children (≤ 18 years) and adults 19-39 years&#xD;
&#xD;
          -  not hospitalized, but confirmed COVID-19 patients (outpatients)&#xD;
&#xD;
          -  patients without definitive COVID-19 confirmation&#xD;
&#xD;
        Control group:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  gender: female/male&#xD;
&#xD;
          -  age: ≥40 years&#xD;
&#xD;
          -  absence of severe illnesses/serious diseases&#xD;
&#xD;
          -  able to give written informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  children (≤ 18 years) and adults 19-39years&#xD;
&#xD;
          -  any current or past clinically significant pathology/disease (comorbidity) such as:&#xD;
&#xD;
               -  Malignancies&#xD;
&#xD;
               -  Cardiovascular diseases&#xD;
&#xD;
               -  Diabetes mellitus (I and II)&#xD;
&#xD;
               -  Obesity class III (BMI &gt;40)&#xD;
&#xD;
               -  Other severe diseases (e.g. renal, hepatic, thyroid disease, bone metabolic&#xD;
                  diseases, rheumatoid osteoarthritis, human immunodeficiency syndrome, …)&#xD;
&#xD;
        Influenza group:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  gender: female/male&#xD;
&#xD;
          -  age: ≥40 years&#xD;
&#xD;
          -  patients admitted at the emergency department&#xD;
&#xD;
          -  influenza suspected patients&#xD;
&#xD;
          -  able to give written informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  children (≤ 18 years) and adults 19-39 years&#xD;
&#xD;
          -  patients without definitive influenza confirmation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karl-Heinz Wagner, PhD</last_name>
    <phone>+4314277</phone>
    <phone_ext>54930</phone_ext>
    <email>karl-heinz.wagner@univie.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik Donaustadt</name>
      <address>
        <city>Vienna</city>
        <zip>1220</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Thell, MD</last_name>
      <phone>+43 67683112550</phone>
      <email>rainer.thell@wienkav.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 3, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vienna</investigator_affiliation>
    <investigator_full_name>Wagner Karl-Heinz</investigator_full_name>
    <investigator_title>Professor of Human Nutrition</investigator_title>
  </responsible_party>
  <keyword>DNA damage</keyword>
  <keyword>Oxidative Stress</keyword>
  <keyword>Inflammation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

